Diurnal control of rod function in the chicken.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMID 1883768)

Published in Vis Neurosci on June 01, 1991

Authors

F Schaeffel1, B Rohrer, T Lemmer, E Zrenner

Author Affiliations

1: Universitaets-Augenklinik Abt. II, Forschungsstelle fuer Experimentelle Ophthalmologie, Tuebingen, Germany.

Articles citing this

Cone signals for spectacle-lens compensation: differential responses to short and long wavelengths. Vision Res (2008) 0.93

Luminance-dependence of spatial vision in budgerigars (Melopsittacus undulatus) and Bourke's parrots (Neopsephotus bourkii). J Comp Physiol A Neuroethol Sens Neural Behav Physiol (2011) 0.93

The contribution of single and double cones to spectral sensitivity in budgerigars during changing light conditions. J Comp Physiol A Neuroethol Sens Neural Behav Physiol (2013) 0.89

Longitudinal chromatic aberration and emmetropization: results from the chicken eye. J Physiol (1992) 0.89

Melatonin potentiates rod signals to ON type bipolar cells in fish retina. J Physiol (2008) 0.87

Analysis of the chicken retina with an adaptive optics multiphoton microscope. Biomed Opt Express (2011) 0.85

Electroretinographic features of the retinopathy, globe enlarged (rge) chick phenotype. Mol Vis (2007) 0.80

The albino chick as a model for studying ocular developmental anomalies, including refractive errors, associated with albinism. Exp Eye Res (2007) 0.80

Compensation to positive as well as negative lenses can occur in chicks reared in bright UV lighting. Vision Res (2012) 0.76

Die Fledermaus: regarding optokinetic contrast sensitivity and light-adaptation, chicks are mice with wings. PLoS One (2013) 0.76

The effect of time of day and repeat reliability on the fast flicker multifocal ERG. Doc Ophthalmol (2000) 0.75

The pattern ERG in chicks - Stimulus dependence and optic nerve section. Vision Res (2016) 0.75

Inhibiting Myopia by (Nearly) Invisible Light? EBioMedicine (2017) 0.75

The chick eye in vision research: An excellent model for the study of ocular disease. Prog Retin Eye Res (2017) 0.75

Articles by these authors

(truncated to the top 100)

Standard for clinical electroretinography (1999 update). International Society for Clinical Electrophysiology of Vision. Doc Ophthalmol (2000) 4.95

Mutations in RPE65 cause Leber's congenital amaurosis. Nat Genet (1997) 4.48

Guidelines for basic pattern electroretinography. Recommendations by the International Society for Clinical Electrophysiology of Vision. Doc Ophthalmol (1997) 3.66

A gene (RPGR) with homology to the RCC1 guanine nucleotide exchange factor is mutated in X-linked retinitis pigmentosa (RP3). Nat Genet (1996) 3.31

Standard for clinical electroretinography (1994 update). Doc Ophthalmol (1995) 2.94

Total colourblindness is caused by mutations in the gene encoding the alpha-subunit of the cone photoreceptor cGMP-gated cation channel. Nat Genet (1998) 2.63

CNGA3 mutations in hereditary cone photoreceptor disorders. Am J Hum Genet (2001) 2.51

An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness. Nat Genet (1998) 2.48

Standard for clinical electro-oculography. International Society for Clinical Electrophysiology of Vision. Doc Ophthalmol (1993) 2.46

Genetics and phenotypes of RPE65 mutations in inherited retinal degeneration. Invest Ophthalmol Vis Sci (2000) 2.46

Selective loss of cone function in mice lacking the cyclic nucleotide-gated channel CNG3. Proc Natl Acad Sci U S A (1999) 2.46

New views on RPE65 deficiency: the rod system is the source of vision in a mouse model of Leber congenital amaurosis. Nat Genet (2001) 2.44

Standard for clinical electro-oculography. International Society for Clinical Electrophysiology of Vision. Arch Ophthalmol (1993) 2.20

Mutations in the CNGB3 gene encoding the beta-subunit of the cone photoreceptor cGMP-gated channel are responsible for achromatopsia (ACHM3) linked to chromosome 8q21. Hum Mol Genet (2000) 2.20

Experiences with the international standard for clinical electroretinography: normative values for clinical practice, interindividual and intraindividual variations and possible extensions. Doc Ophthalmol (1993) 2.03

Electrical multisite stimulation of the isolated chicken retina. Vision Res (2000) 1.82

Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2. Am J Physiol (1999) 1.77

Biochemical but not clinical vitamin A deficiency results from mutations in the gene for retinol binding protein. Am J Clin Nutr (1999) 1.65

Inter-individual variability in the dynamics of natural accommodation in humans: relation to age and refractive errors. J Physiol (1993) 1.60

Hepatic retinopathia. Changes in retinal function. Vision Res (1997) 1.58

OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance. Hum Mol Genet (2001) 1.54

Intensity modulated proton therapy: a clinical example. Med Phys (2001) 1.49

Retinal prosthesis: an encouraging first decade with major challenges ahead. Ophthalmology (2001) 1.48

Genetic heterogeneity among blue-cone monochromats. Am J Hum Genet (1993) 1.47

Enchancement of luminance flicker by color-opponent mechanisms. Science (1979) 1.46

Evaluation of the rhodopsin knockout mouse as a model of pure cone function. Invest Ophthalmol Vis Sci (2001) 1.40

Extraocular surgery for implantation of an active subretinal visual prosthesis with external connections: feasibility and outcome in seven patients. Br J Ophthalmol (2008) 1.39

Phenotype in retinol deficiency due to a hereditary defect in retinol binding protein synthesis. Invest Ophthalmol Vis Sci (1999) 1.36

Electrophysiology in the investigation of acquired retinal disorders. Surv Ophthalmol (2000) 1.35

Multifocal electroretinography in retinitis pigmentosa. Am J Ophthalmol (1998) 1.34

Stereotactic fractionated irradiation of optic nerve sheath meningioma: a new treatment alternative. Br J Ophthalmol (2002) 1.28

Mouse choroideremia gene mutation causes photoreceptor cell degeneration and is not transmitted through the female germline. Hum Mol Genet (1997) 1.27

Human tritanopia associated with two amino acid substitutions in the blue-sensitive opsin. Am J Hum Genet (1992) 1.27

Constant light affects retinal dopamine levels and blocks deprivation myopia but not lens-induced refractive errors in chickens. Vis Neurosci (1994) 1.24

Twelve novel myosin VIIA mutations in 34 patients with Usher syndrome type I: confirmation of genetic heterogeneity. Hum Mutat (1999) 1.22

Self-complementary AAV-mediated gene therapy restores cone function and prevents cone degeneration in two models of Rpe65 deficiency. Gene Ther (2010) 1.21

Robot-aided neurorehabilitation: from evidence-based to science-based rehabilitation. Top Stroke Rehabil (2002) 1.21

The role of the peripherin/RDS gene in retinal dystrophies. Acta Anat (Basel) (1998) 1.20

6-Hydroxy dopamine does not affect lens-induced refractive errors but suppresses deprivation myopia. Vision Res (1994) 1.19

Horner's syndrome: a retrospective analysis of 90 cases and recommendations for clinical handling. Ger J Ophthalmol (1992) 1.18

Studies on the role of the retinal dopamine/melatonin system in experimental refractive errors in chickens. Vision Res (1995) 1.16

Human rod monochromacy: linkage analysis and mapping of a cone photoreceptor expressed candidate gene on chromosome 2q11. Genomics (1998) 1.15

Three novel rhodopsin mutations (C110F, L131P, A164V) in patients with autosomal dominant retinitis pigmentosa. Hum Mol Genet (1994) 1.15

Clinical applications of multifocal electroretinography. Doc Ophthalmol (2000) 1.11

Is colour vision possible with only rods and blue-sensitive cones? Nature (1991) 1.11

Multifocal electroretinography in patients with Stargardt's macular dystrophy. Br J Ophthalmol (1998) 1.11

RDS/peripherin gene mutations are frequent causes of central retinal dystrophies. J Med Genet (1997) 1.09

Pupil perimetry using M-sequence stimulation technique. Invest Ophthalmol Vis Sci (2000) 1.08

Mutation analysis of the ND6 gene in patients with Lebers hereditary optic neuropathy. Biochem Biophys Res Commun (1997) 1.07

Neuroprotective strategies for the treatment of inherited photoreceptor degeneration. Curr Mol Med (2012) 1.07

Slow and fast rod ERG pathways in patients with X-linked complete stationary night blindness carrying mutations in the NYX gene. Invest Ophthalmol Vis Sci (2001) 1.05

Plasminogen kringle 5 reduces vascular leakage in the retina in rat models of oxygen-induced retinopathy and diabetes. Diabetologia (2003) 1.05

Prevention of photoreceptor apoptosis by activation of the glucocorticoid receptor. Invest Ophthalmol Vis Sci (2001) 1.03

Detection and characterization of point mutations in the choroideremia candidate gene by PCR-SSCP analysis and direct DNA sequencing. Am J Hum Genet (1992) 1.02

Cone and rod function in cone degenerations. Vision Res (1997) 1.02

Spatial cone activity distribution in diseases of the posterior pole determined by multifocal electroretinography. Vision Res (1998) 0.99

Slow and fast pathways in the human rod visual system: electrophysiology and psychophysics. J Opt Soc Am A (1991) 0.99

Long-term survival of retinal cell cultures on retinal implant materials. Vision Res (1999) 0.98

Cloning, chromosomal localization and functional expression of the gene encoding the alpha-subunit of the cGMP-gated channel in human cone photoreceptors. Eur J Neurosci (1997) 0.98

Current source density analysis of linear and non-linear components of the primate electroretinogram. J Physiol (1988) 0.97

A genetic perspective on myopia. Cell Mol Life Sci (2005) 0.97

Studies on the feasibility of a subretinal visual prosthesis: data from Yucatan micropig and rabbit. Graefes Arch Clin Exp Ophthalmol (2001) 0.97

The photoreceptors in atypical achromatopsia. J Physiol (1989) 0.96

Characteristics of the blue sensitive cone mechanism in primate retinal ganglion cells. Vision Res (1981) 0.95

Effects of ethyl alcohol on the electrooculogram and color vision. Doc Ophthalmol (1986) 0.95

Mutations in the human peripherin/RDS gene associated with autosomal dominant retinitis pigmentosa. Hum Mutat (1994) 0.95

Extensive intrafamilial and interfamilial phenotypic variation among patients with autosomal dominant retinal dystrophy and mutations in the human RDS/peripherin gene. Br J Ophthalmol (1995) 0.95

A preliminary trial to determine whether prevention of dark adaptation affects the course of early diabetic retinopathy. Eye (Lond) (2010) 0.95

[Subretinal visual implants]. Klin Monbl Augenheilkd (2010) 0.95

Evaluation of the Night Vision Spectacles on patients with impaired night vision. Graefes Arch Clin Exp Ophthalmol (1999) 0.94

Development of the retinotectal projection in zebrafish embryos under TTX-induced neural-impulse blockade. J Neurosci (1990) 0.94

Implicit time topography of multifocal electroretinograms. Invest Ophthalmol Vis Sci (1998) 0.93

Deletions in exon 5 of the human rhodopsin gene causing a shift in the reading frame and autosomal dominant retinitis pigmentosa. Hum Genet (1992) 0.93

Mizuo phenomenon in X-linked retinoschisis. Pathogenesis of the Mizuo phenomenon. Arch Ophthalmol (1991) 0.93

Long-term platinum excretion in patients treated with cisplatin. Cancer Chemother Pharmacol (1995) 0.92

Novel rhodopsin mutations and genotype-phenotype correlation in patients with autosomal dominant retinitis pigmentosa. Br J Ophthalmol (2005) 0.92

A proposal for the documentation of clinically applied color vision tests. Dev Ophthalmol (1984) 0.92

GPR98 mutations cause Usher syndrome type 2 in males. J Med Genet (2009) 0.91

["Oligocone" trichromasy, a rare form of incomplete achromatopsia]. Ophthalmologe (1997) 0.91

Temporal properties of marmoset lateral geniculate cells. Vision Res (1997) 0.91

Multifocal oscillatory potentials in type 1 diabetes without retinopathy. Invest Ophthalmol Vis Sci (2000) 0.91

The influence of phosphodiesterase inhibitors on ERG and optic nerve response of the cat. Invest Ophthalmol Vis Sci (1986) 0.91

Identification of Usher syndrome subtypes by ERG implicit time. Invest Ophthalmol Vis Sci (2001) 0.91

In vitro identification of retinal ganglion cells in culture without the need of dye labeling. J Neurosci Methods (1994) 0.90

Retinoschisislike alterations in the mouse eye caused by gene targeting of the Norrie disease gene. Invest Ophthalmol Vis Sci (1997) 0.90

[Retinitis pigmentosa - a review. Pathogenesis, guidelines for diagnostics and perspectives]. Ophthalmologe (2012) 0.90

Effects of brain-derived neurotrophic factor on dopaminergic function and motor behavior during aging. Genes Brain Behav (2010) 0.90

[Status of the subretinal implant project. An overview]. Ophthalmologe (2005) 0.89

Off-components in response to brief light flashes in the oscillatory potential of the human electroretinogram. Albrecht Von Graefes Arch Klin Exp Ophthalmol (1978) 0.89

Ocular findings in a family with autosomal dominant retinitis pigmentosa and a frameshift mutation altering the carboxyl terminal sequence of rhodopsin. Br J Ophthalmol (1993) 0.89

Longitudinal chromatic aberration and emmetropization: results from the chicken eye. J Physiol (1992) 0.89

Analysis of 21 Stargardt's disease families confirms a major locus on chromosome 1p with evidence for non-allelic heterogeneity in a minority of cases. Br J Ophthalmol (1996) 0.89

A novel mutation of the RP1 gene (Lys778ter) associated with autosomal dominant retinitis pigmentosa. Br J Ophthalmol (2002) 0.88

Asymmetries in the time-course of chromatic adaptation and the significance of contrast. Vision Res (2000) 0.88

Brightness matching and colour discrimination in young diabetics without retinopathy. Vision Res (1994) 0.88

Electroretinographic campimetry in a patient with crystalline retinopathy. Ger J Ophthalmol (1996) 0.88

["Glare vision". I. Physiological principles of vision change with increased test field luminance]. Klin Monbl Augenheilkd (1992) 0.87

Evaluation of the gene encoding the tissue inhibitor of metalloproteinases-3 in various maculopathies. Invest Ophthalmol Vis Sci (1997) 0.87

Linkage of X-linked retinitis pigmentosa to the hypervariable DNA marker M27 beta (DXS255). Hum Genet (1989) 0.87

Prognostic value of the pattern electroretinogram in cases of tumors affecting the optic pathway. Graefes Arch Clin Exp Ophthalmol (1998) 0.86